Increasing our understanding of human cognition through the study of fragile X syndrome

Developmental Neurobiology

Volumn 74, Issue 2, 2014, Pages 147-177

  Cook, Denise ^a   Nuro, Erin ^a   Murai, Keith K ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cognition; Connectivity; FMRP; Fragile X Syndrome; FXR1P; FXR2P; Local protein synthesis; Plasticity; Synapses

Indexed keywords

BRAIN PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X RELATED PROTEIN 1; FRAGILE X RELATED PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; BRAIN DEVELOPMENT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DENDRITIC SPINE; DEVELOPMENTAL STAGE; EXCITABILITY; FRAGILE X SYNDROME; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RNA STABILITY; RNA TRANSPORT; SPATIAL MEMORY; SYNAPSE; TRANSLATION REGULATION;

COGNITION; CONNECTIVITY; FMRP; FRAGILE X SYNDROME; FXR1P; FXR2P; LOCAL PROTEIN SYNTHESIS; PLASTICITY; SYNAPSES;

ANIMALS; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITION; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; NEURONS;

EID: 84891901978     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.22096     Document Type: Article

References (386)

1. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J. 1993. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 4:147-153.
2. Abrahams BS, Geschwind DH. 2008. Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet 9:341-355.
3. Adinolfi S, Bagni C, Castiglione MA, Fraternali F, Musco G, Pastore A. 1999. Novel RNA-binding motif: The KH module. Biopolymers 51:153-164.
4. Adinolfi S, Bagni C, Musco G, Gibson T, Mazzarella L, Pastore A. 1999. Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains. RNA 5:1248-1258.
5. Adinolfi S, Ramos A, Martin SR, Dal Piaz F, Pucci P, Bardoni B, Mandel JL, et al. 2003. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding. Biochemistry 42:10437-10444.
6. Ainger K, Avossa D, Morgan F, Hill SJ, Barry C, Barbarese E, Carson JH. 1993. Transport and localization of exogenous myelin basic protein mRNA microinjected into oligodendrocytes. J Cell Biol 123:431-441.
7. Akins MR, Berk-Rauch HE, Fallon JR. 2009. Presynaptic translation: Stepping out of the postsynaptic shadow. Front Neural Circuits 3:17.
8. Akins MR, Leblanc HF, Stackpole EE, Chyung E, Fallon JR. 2012. Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions. J Comp Neurol 520:3687-3706.
9. Antar LN, Afroz R, Dictenberg J B, Carroll RC, Bassell GJ. 2004. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24:2648-2655.
10. Antar LN, Dictenberg JB, Plociniak M, Afroz R, Bassell GJ. 2005. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav 4:350-359.
11. Antar LN, Li C, Zhang H, Carroll RC, Bassell GJ. 2006. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci 32:37-48.
12. Antion MD, Hou L, Wong H, Hoeffer CA, Klann E. 2008. mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice. Mol Cell Biol 28:2996-3007.
13. Ascano M, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, Langlois C, et al. 2012. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492:382-386.
14. Aschrafi A, Cunningham BA, Edelman GM, Vanderklish PW. 2005. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci USA 102:2180-2185.
15. Ashley CT, Wilkinson KD, Reines D, Warren ST. 1993. FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262:563-566.
16. Ashley CT, Sutcliffe JS, Kunst CB, Leiner HA, Eichler EE, Nelson DL, Warren ST. 1993. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 4:244-251.
17. Auerbach BD, Bear MF. 2010. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis. J Neurophysiol 104:1047-1051.
18. Auerbach BD, Osterweil EK, Bear MF. 2011. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480:63-68.
19. Autilio LA, Appel SH, Pettis P, Gambetti PL. 1968. Biochemical studies of synapses in vitro. I. Protein synthesis. Biochemistry 7:2615-2622.
20. Backman S, Stambolic V, Mak T. 2002. PTEN function in mammalian cell size regulation. Curr Opin Neurobiol 12:516-522.
21. Bailey DB, Hazlett HC, Roberts JE, Wheeler AC. 2011. Early Development in Fragile X Syndrome: Implications for Developmental Screening. In: Deborah J. Fidler, editor. International Review of Research in Developmental Disabilities, Vol. 40. San Diego, CA: Elsevier, p 75-108.
22. Bakker CE, De Diego Otero Y, Bontekoe C, Raghoe P, Luteijn T, Hoogeveen AT, Oostra BA, Willemsen R. 2000. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 258:162-170.
23. Banko JL, Hou L, Poulin F, Sonenberg N, Klann E. 2006. Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J Neurosci 26:2167-2173.
24. Baranek GT, Roberts JE, David FJ, Sideris J, Mirrett PL, Hatton DD, Bailey DB. 2008. Developmental trajectories and correlates of sensory processing in young boys with fragile X syndrome. Phys Occup Ther Pediatr 28:79-98.
25. Barbee SA, Estes PS, Cziko A-M, Hillebrand J, Luedeman RA, Coller JM, Johnson N, et al. 2006. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 52:997-1009.
26. Barbosa AC, Kim M-S, Ertunc M, Adachi M, Nelson ED, McAnally J, Richardson JA, et al. 2008. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci USA 105:9391-9396.
27. Bardoni B, Davidovic L, Bensaid M, Khandjian EW. 2006. The fragile X syndrome: Exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8:1-16.
28. Bassell GJ, Warren ST. 2008. Fragile X syndrome: Loss of local mRNA regulation alters synaptic development and function. Neuron 60:201-14.
29. Bateup HS, Takasaki KT, Saulnier JL, Denefrio CL, Sabatini BL. 2011. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J Neurosci 31:8862-8869.
30. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci 27:370-377.
31. Bechara EG, Didiot MC, Melko M, Davidovic L, Bensaid M, Martin P, Castets M, et al. 2009. A novel function for fragile X mental retardation protein in translational activation. PLoS Biol 7:e16.
32. Bhakar AL, Dölen G, Bear Mark F. 2012. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 35:417-443.
33. Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E. 2012. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 76:325-337.
34. Bhattacharyya A, McMillan E, Wallace K, Tubon TC, Capowski EE, Svendsen CN. 2008. Normal neurogenesis but abnormal gene expression in human fragile X cortical progenitor cells. Stem Cells Dev 17:107-117.
35. Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, Ethell IM. 2009. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46:94-102.
36. Blackwell E, Zhang X, Ceman S. 2010. Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA. Hum Mol Genet 19:1314-1323.
37. Blonden L, Van't Padje S, Severijnen L-A, Destree O, Oostra BA, Willemsen R. 2005. Two members of the Fxr gene family, Fmr1 and Fxr1, are differentially expressed in Xenopus tropicalis. Int J Dev Biol 49:437-441.
38. Bodian D. 1965. A suggestive relationship of nerve cell RNA with specific synaptic sites. Proc Natl Acad Sci USA:418-425.
39. Bogdanik L, Mohrmann R, Ramaekers A, Bockaert J, Grau Y, Broadie K, Parmentier M-L. 2004. The Drosophila metabotropic glutamate receptor DmGluRA regulates activity-dependent synaptic facilitation and fine synaptic morphology. J Neurosci 24:9105-9116.
40. Bolduc FV, Bell K, Cox H, Broadie KS, Tully T. 2008. Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat Neurosci 11:1143-1145.
41. Bongmba OYN, Martinez LA, Elhardt ME, Butler K, Tejada-Simon MV. 2011. Modulation of dendritic spines and synaptic function by Rac1: A possible link to Fragile X syndrome pathology. Brain Res 1399:79-95.
42. Bontekoe CJM, McIlwain KL, Nieuwenhuizen IM, Yuva-Paylor LA, Nellis A, Willemsen R, Fang Z, et al. 2002. Knockout mouse model for Fxr2: A model for mental retardation. Hum Mol Genet 11:487-498.
43. De Boulle K, Verkerk AJ, Reyniers E, Vits L, Hendrickx J, Van Roy B, Van den Bos F, et al. 1993. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 3:31-35.
44. Bourgeron T. 2009. A synaptic trek to autism. Curr Opin Neurobiol 19:231-234.
45. Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B, Panja D, et al. 2010. The Arc of synaptic memory. Exp Brain Res. 200:125-140.
46. Bray S, Hirt M, Jo B, Hall SSS, Lightbody AA, Walter E, Chen K, et al. 2011. Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation. Biol Psychiatry 70:852-858.
47. Von der Brelie C, Waltereit R, Zhang L, Beck H, Kirschstein T. 2006. Impaired synaptic plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23:686-692.
48. Brown MR, Kronengold J, Gazula V-R, Chen Y, Strumbos JG, Sigworth FJ, Navaratnam D, Kaczmarek LK. 2010. Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. Nat Neurosci 13:819-821.
49. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, et al. 2001. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487.
50. Budimirovic DB, Kaufmann WE. 2011. What can we learn about autism from studying fragile X syndrome? Dev Neurosci 33:379-394.
51. Bureau I, Shepherd GMG, Svoboda Karel. 2008. Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knockout mice. J Neurosci 28:5178-5188.
52. Bushey D, Tononi G, Cirelli C. 2009. The Drosophila fragile X mental retardation gene regulates sleep need. J Neurosci 29:1948-1961.
53. Callan MA, Cabernard C, Heck J, Luois S, Doe CQ, Zarnescu DC. 2010. Fragile X protein controls neural stem cell proliferation in the Drosophila brain. Hum Mol Genet 19:3068-3079.
54. Callan MA, Zarnescu DC. 2011. Heads-up: New roles for the fragile X mental retardation protein in neural stem and progenitor cells. Genesis 49:424-440.
55. Campbell DS, Holt CE. 2001. Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32:1013-1026.
56. Carroll RC, Lissin DV, Von Zastrow M, Nicoll RA, Malenka RC. 1999. Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures. Nat Neurosci 2:454-460.
57. Castrén E, Elgersma Y, Maffei L, Hagerman R, Castren E. 2012. Treatment of neurodevelopmental disorders in adulthood. J Neurosci 32:14074-14079.
58. Castrén M, Tervonen T, Kärkkäinen V, Heinonen S, Castrén E, Larsson K, Bakker CE, et al. 2005. Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci USA 102:17834-17839.
59. Caudy AA, Hannon GJ. 2004. Induction and biochemical purification of RNA-induced silencing complex from Drosophila S2 cells. Methods Mol Biol 265:59-72.
60. Caudy AA, Myers M, Hannon GJ, Hammond SM. 2002. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 16:2491-2496.
61. CDC. 2012. Data and Statistics, Autism Spectrum Disorders. Atlanta, GA: National Center on Birth Defects and Developmental Disabilities. Available at: http://www.cdc.gov/ncbddd/autism/data.html. Last accessed May 10, 2013.
62. Ceman S, O'Donnell WT, Reed M, Patton S, Pohl J, Warren ST. 2003. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet 12:3295-3305.
63. Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, et al. 2008. Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol Psychiatry 63:963-973.
64. Cheever A, Ceman S. 2009a. Phosphorylation of FMRP inhibits association with Dicer. RNA 15:362-366.
65. Cheever A, Ceman S. 2009b. Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway. RNA Biol 6:175-178.
66. Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, Kuhl D, et al. 2006. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52:445-459.
67. Christie SB, Akins MR, Schwob JE, Fallon JR. 2009. The FXG: A presynaptic fragile X granule expressed in a subset of developing brain circuits. J Neurosci 29:1514-1524.
68. Chévere-Torres I, Kaphzan H, Bhattacharya A, Kang A, Maki JM, Gambello MJ, Arbiser JL, et al. 2012. Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex. Neurobiol Dis 45:1101-1110.
69. Chévere-Torres I, Maki JM, Santini E, Klann E. 2012. Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin. Neurobiol Dis 45:156-164.
70. Clark IE, Wyckoff D, Gavis ER. 2000. Synthesis of the posterior determinant Nanos is spatially restricted by a novel cotranslational regulatory mechanism. Curr Biol 10:1311-1314.
71. Coffee B, Ikeda M, Budimirovic DB, Hjelm LN, Kaufmann WE, Warren ST. 2008. Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: A case report and review of the literature. Am J Med Genet A 146:1358-1367.
72. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT. 1997. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401-5404.
73. Cook D, Del Rayo Sanchez-Carbente M, Lachance C, Radzioch D, Tremblay S, Khandjian EW, DesGroseillers L, et al. 2011. Fragile X related protein 1 clusters with ribosomes and messenger rnas at a subset of dendritic spines in the mouse hippocampus. Chavis P, editor. PLoS One 6:e26120.
74. Corbin F, Bouillon M, Fortin A, Morin S, Rousseau F, Khandjian EW. 1997. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum Mol Genet 6:1465-1472.
75. Cornish KM, Kogan CS, Li L, Turk J, Jacquemont S, Hagerman RJ. 2009. Lifespan changes in working memory in fragile X premutation males. Brain Cogn 69:551-558.
76. Costa-Mattioli M, Gobert D, Harding H, Herdy B, Azzi M, Bruno M, Bidinosti M, et al. 2005. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 436:1166-1173.
77. Costa-Mattioli M, Gobert D, Stern E, Gamache K, Colina R, Cuello C, Sossin W, et al. 2007. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 129:195-206.
78. Costa-Mattioli M, Sonenberg N, Richter JD. 2009. Translational regulatory mechanisms in synaptic plasticity and memory storage. Prog Mol Biol Transl Sci 90:293-311.
79. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N. 2009. Translational control of long-lasting synaptic plasticity and memory. Neuron 61:10-26.
80. Cruz-Martín A, Crespo M, Portera-Cailliau C. 2010. Delayed stabilization of dendritic spines in fragile X mice. J Neurosci 30:7793-7803.
81. Cruz-Martín A, Crespo M, Portera-Cailliau C. 2012. Glutamate induces the elongation of early dendritic protrusions via mGluRs in wild type mice, but not in fragile X mice. PLoS One 7:e32446.
82. Currie JR, Brown WT. 1999. KH domain-containing proteins of yeast: Absence of a fragile X gene homologue. Am J Med Genet 84:272-276.
83. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. 2001. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107:489-499.
84. Darnell JC. 2011. Defects in translational regulation contributing to human cognitive and behavioral disease. Curr Opin Genet Dev 21:465-473.
85. Darnell JC, Van Driesche SJ, Zhang C, Hung KYS, Mele A, Fraser CE, Stone EFF, et al. 2011. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247-261.
86. Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, Eddy SR, Darnell RB. 2005. Kissing complex RNAs mediate interaction between the fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 19:903-918.
87. Dasgupta B, Gutmann DH. 2003. Neurofibromatosis 1: Closing the GAP between mice and men. Curr Opin Genet Dev 13:20-27.
88. Davidovic L, Bechara E, Gravel M, Jaglin XH, Tremblay S, Sik A, Bardoni B, et al. 2006. The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons. Hum Mol Genet 15:1525-1538.
89. Davidovic L, Jaglin XH, Lepagnol-Bestel A-M, Tremblay S, Simonneau M, Bardoni B, Khandjian EW. 2007. The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum Mol Genet 16:3047-3058.
90. Deng P-Y, Sojka D, Klyachko VA. 2011. Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. J Neurosci 31:10971-10982.
91. Deng W, Aimone JB, Gage FH. 2010. New neurons and new memories: How does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 11:339-350.
92. Desai NS, Casimiro TM, Gruber SM, Vanderklish PW. 2006. Early postnatal plasticity in neocortex of Fmr1 knockout mice. J Neurophysiol 96:1734-1745.
93. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
94. Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. 2008. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 14:926-939.
95. De Diego Otero Yolanda, Severijnen L-A, Van Cappellen G, Schrier M, Oostra B, Willemsen Rob. 2002. Transport of fragile X mental retardation protein via granules in neurites of PC12 cells. Mol Cell Biol 22:8332-8341.
96. Dockendorff TC, Su HS, McBride SMJ, Yang Z, Choi CH, Siwicki KK, Sehgal A, Jongens TA. 2002. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34:973-984.
97. Dolzhanskaya N, Merz G, Aletta JM, Denman RB. 2006. Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP. J Cell Sci 119:1933-1946.
98. Dolzhanskaya N, Merz G, Denman RB. 2006. Alternative splicing modulates protein arginine methyltransferase-dependent methylation of fragile X syndrome mental retardation protein. Biochemistry 45:10385-10393.
99. Doyle M, Kiebler MA. 2011. Mechanisms of dendritic mRNA transport and its role in synaptic tagging. EMBO J 30:3540-3552.
100. Dziembowska M, Wlodarczyk J. 2012. MMP9: A novel function in synaptic plasticity. Int J Biochem Cell Biol 44:709-713.
101. Dölen G, Osterweil E, Rao BSS, Smith GB, Auerbach BD, Chattarji S, Bear MF. 2007. Correction of fragile X syndrome in mice. Neuron 56:955-962.
102. D'Antuono M, Merlo D, Avoli M. 2003. Involvement of cholinergic and gabaergic systems in the fragile X knockout mice. Neuroscience 119:9-13.
103. D'Hulst C, De Geest N, Reeve SP, Van Dam D, De Deyn Peter P, Hassan BA, Kooy RF. 2006. Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 1121:238-245.
104. Eadie BD, Zhang WN, Boehme F, Gil-Mohapel J, Kainer L, Simpson JM, Christie BR. 2009. Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus. Neurobiol Dis 36:361-373.
105. Eberhart DE, Malter HE, Feng Y, Warren ST. 1996. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5:1083-1091.
106. Eberwine J, Belt B, Kacharmina JE, Miyashiro K. 2002. Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem Res 27:1065-1077.
107. Edbauer D, Neilson JR, Foster KA, Wang C-F, Seeburg DP, Batterton MN, Tada T, et al. 2010. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65:373-384.
108. Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, Ramesh V, et al. 2008. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 14:843-848.
109. Eliez S, Blasey CM, Freund LS, Hastie T, Reiss AL. 2001. Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. Brain 124:1610-1618.
110. Elvira G, Wasiak S, Blandford V, Tong X-KK, Serrano A, Fan X, Del Rayo Sanchez-Carbente M, et al. 2006. Characterization of an RNA granule from developing brain. Mol. Cell. Proteomics 5:635-651.
111. Estes PS, O'Shea M, Clasen S, Zarnescu DC. 2008. Fragile X protein controls the efficacy of mRNA transport in Drosophila neurons. Mol Cell Neurosci 39:170-179.
112. Evans TL, Blice-Baum AC, Mihailescu M-R. 2012. Analysis of the Fragile X mental retardation protein isoforms 1, 2 and 3 interactions with the G-quadruplex forming semaphorin 3F mRNA. Mol Biosyst 8:642-649.
113. Fabian MR, Cieplak MK, Frank F, Morita M, Green J, Srikumar T, Nagar B, et al. 2011. miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT. Nat Struct Mol Biol 18:1211-1217.
114. El Fatimy R, Tremblay S, Dury AY, Solomon S, De Koninck P, Schrader JW, Khandjian EW. 2012. Fragile mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes. Brosius J, editor. PLoS One 7:e39338.
115. Feng Y, Absher D, Eberhart DE, Brown V, Malter HE, Warren ST. 1997. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1:109-118.
116. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. 1997. Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.
117. Ferraguti F, Baldani-Guerra B, Corsi M, Nakanishi S, Corti C. 1999. Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors. Eur J Neurosci 11:2073-2082.
118. Ferrari F, Mercaldo V, Piccoli G, Sala C, Cannata S, Achsel T, Bagni C. 2007. The fragile X mental retardation protein-RNP granules show an mGluR-dependent localization in the post-synaptic spines. Mol Cell Neurosci 34:343-354.
119. Fiala JC, Feinberg M, Popov V, Harris KM. 1998. Synaptogenesis via dendritic filopodia in developing hippocampal area CA1. J Neurosci 18:8900-8911.
120. Flavell SW, Cowan CW, Kim T-K, Greer PL, Lin Y, Paradis S, Griffith EC, et al. 2006. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008-1012.
121. Frey U, Krug M, Brödemann R, Reymann K, Matthies H. 1989. Long-term potentiation induced in dendrites separated from rat's CA1 pyramidal somata does not establish a late phase. Neurosci Lett 97:135-139.
122. Fähling M, Mrowka R, Steege A, Kirschner KM, Benko E, Förstera B, Persson PB, et al. 2009. Translational regulation of the human achaete-scute homologue-1 by fragile X mental retardation protein. J Biol Chem 284:4255-4266.
123. Gabel LA, Won S, Kawai H, McKinney M, Tartakoff AM, Fallon JR. 2004. Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein. J Neurosci 24:10579-10583.
124. Gabus C, Mazroui R, Tremblay S, Khandjian EW, Darlix J-L. 2004. The fragile X mental retardation protein has nucleic acid chaperone properties. Nucleic Acids Res 32:2129-2137.
125. Gallagher SM, Daly CA, Bear MF, Huber KM. 2004. Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1. J Neurosci 24:4859-4864.
126. Galvez R, Gopal AR, Greenough WT. 2003. Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome. Brain Res 971:83-89.
127. Galvez R, Greenough WT. 2005. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am J Med Genet A 135:155-160.
128. Gantois I, Vandesompele J, Speleman F, Reyniers E, D'Hooge R, Severijnen L-A, Willemsen R, et al. 2006. Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis 21:346-357.
129. Garthe A, Behr J, Kempermann G. 2009. Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS One 4:e5464.
130. Gary JD, Clarke S. 1998. RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61:65-131.
131. Gatto CL, Broadie K. 2008. Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure. Development 135:2637-2648.
132. Gerlai R, Gerlai J. 2004. Autism: A target of pharmacotherapies? Drug Discov Today 9:366-374.
133. Gkogkas CG, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, Weatherill DB, Vasuta C, et al. 2013. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493:371-377.
134. Godfraind JM, Reyniers E, De Boulle K, D'Hooge R, De Deyn PP, Bakker CE, Oostra BA, et al. 1996. Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet 64:246-251.
135. Goebel-Goody SM, Wilson-Wallis ED, Royston S, Tagliatela SM, Naegele JR, Lombroso P. 2012. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Genes Brain Behav 11:586-600.
136. Goebel-Goody SM, Lombroso PJ. 2012. Taking STEPs forward to understand fragile X syndrome. Results Probl Cell Differ 54:223-241.
137. Gothelf D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O'Hara R, Erba HW, et al. 2008. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol 63:40-51.
138. Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ. 2011. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. J Neurosci 31:5693-5698.
139. Grossman AW, Elisseou NM, McKinney BC, Greenough WT. 2006. Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res 1084:158-164.
140. Grønskov K, Brøndum-Nielsen K, Dedic A, Hjalgrim H. 2011. A nonsense mutation in FMR1 causing fragile X syndrome. Eur J Hum Genet 19:489-491.
141. Gu Y, Lugenbeel KA, Vockley JG, Grody WW, Nelson DL. 1994. A de novo deletion in FMR1 in a patient with developmental delay. Hum Mol Genet 3:1705-1706.
142. Guduric-Fuchs J, Möhrlen F, Frohme M, Frank U. 2004. A fragile X mental retardation-like gene in a cnidarian. Gene 343:231-238.
143. Guo W, Allan AM, Zong R, Zhang Li, Johnson EB, Schaller EG, Murthy AC, et al. 2011. Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning. Nat Med 17:559-565.
144. Götz M, Huttner WB. 2005. The cell biology of neurogenesis. Nat Rev Mol Cell Biol 6:777-788.
145. Hagerman Paul J. 2008. The fragile X prevalence paradox. J Med Genet 45:498-499.
146. Hagerman P, Stafstrom C. 2009. Origins of epilepsy in fragile X syndrome. Epilepsy Curr 9:108-112.
147. Hagerman R, Hoem G, Hagerman P. 2010. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism 1:12.
148. Harlow EG, Till SM, Russell TA, Wijetunge LS, Kind P, Contractor A. 2010. Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. Neuron 65:385-398.
149. Hayashi ML, Choi S-Y, Rao BSS, Jung H-Y, Lee H-K, Zhang D, Chattarji S, et al. 2004. Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice. Neuron 42:773-787.
150. Hayashi ML, Rao BSS, Seo J-S, Choi H-S, Dolan BM, Choi S-Y, Chattarji S, et al. 2007. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104:11489-11494.
151. Hessl D, Rivera S, Reiss A. 2004. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev 24:17-24.
152. Hessl D, Wang JM, Schneider A, Koldewyn K, Le L, Iwahashi C, Cheung K, et al. 2011. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biol Psychiatry 70:859-865.
153. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD. 1991. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41:289-294.
154. Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen DV, Wong H, Whelan AM, et al. 2012. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav 11:332-341.
155. Hoeffer CA, Tang W, Wong H, Santillan A, Patterson RJ, Martinez LA, Tejada-Simon MV, et al. 2008. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60:832-845.
156. Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E. 2006. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51:441-454.
157. Hou L, Klann E. 2004. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24:6352-6361.
158. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. 2006. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843.
159. Huber KM, Kayser MS, Bear MF. 2000. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288:1254-1256.
160. Huber KM, Gallagher SM, Warren ST, Bear MF. 2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746-7750.
161. Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MCJ, Merrick WC, et al. 2011. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 41:419-431.
162. Iacoangeli A, Rozhdestvensky TS, Dolzhanskaya N, Tournier B, Schütt J, Brosius J, Denman RB, et al. 2008. On BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci USA 105:734-739.
163. Iarocci G, McDonald J. 2006. Sensory integration and the perceptual experience of persons with autism. J Autism Dev Disord 36:77-90.
164. Inoue S, Shimoda M, Nishinokubi I, Siomi MC, Okamura M, Nakamura A, Kobayashi S, et al. 2002. A role for the Drosophila fragile X-related gene in circadian output. Curr Biol 12:1331-1335.
165. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, et al. 2012. De novo gene disruptions in children on the autistic spectrum. Neuron 74:285-299.
166. Irwin SA, Galvez R, Greenough WT. 2000. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 10:1038-1044.
167. Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP, Kooy F, et al. 2001. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am J Med Genet 98:161-167.
168. Irwin SA, Swain RA, Christmon CA, Chakravarti A, Weiler IJ, Greenough WT. 2000. Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol Learn Mem 74:87-93.
169. Irwin SA, Christmon CA, Grossman AW, Galvez R, Kim SH, DeGrush BJ, Weiler IJ, et al. 2005. Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis. Neurobiol Learn Mem 83:180-187.
170. Irwin SA, Idupulapati M, Gilbert ME, Harris JB, Chakravarti AB, Rogers EJ, Crisostomo RA, et al. 2002. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet 111:140-146.
171. Ishizuka A, Siomi MC, Siomi H. 2002. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 16:2497-2508.
172. Jacobs S, Doering LC. 2010. Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci 30:4508-4514.
173. Jacobs S, Nathwani M, Doering LC. 2010. Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci 11:132.
174. Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg IC, Soderstrom H, et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27-29.
175. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA, Nelson DL, et al. 2004. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 7:113-117.
176. Johnson EM, Kinoshita Y, Weinreb DB, Wortman MJ, Simon R, Khalili K, Winckler B, et al. 2006. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res 83:929-943.
177. Jope RS, Johnson GVW. 2004. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102.
178. Juraska JM, Fifkova E. 1979a. A Golgi study of the early postnatal development of the visual cortex of the hooded rat. J Comp Neurol 183:247-256.
179. Juraska JM, Fifkova E. 1979b. An electron microscope study of the early postnatal development of the visual cortex of the hooded rat. J Comp Neurol 183:257-267.
180. Juraska JM. 1982. The development of pyramidal neurons after eye opening in the visual cortex of hooded rats: A quantitative study. J Comp Neurol 212:208-213.
181. Kang H, Schuman EM. 1995. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267:1658-1662.
182. Kaufmann WE, Cortell R, Kau ASM, Bukelis I, Tierney E, Gray RM, Cox C, et al. 2004. Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors. Am J Med Genet A 129:225-234.
183. Kedersha N, Anderson P. 2007. Mammalian stress granules and processing bodies. Methods Enzymol 431:61-81.
184. Kelleher RJ, Bear MF. 2008. The autistic neuron: Troubled translation? Cell 135:401-406.
185. Kelleher RJ, Govindarajan A, Jung H-Y, Kang H, Tonegawa S. 2004. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116:467-479.
186. Kelleher RJ, Govindarajan A, Tonegawa S. 2004. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44:59-73.
187. Kern JK, Trivedi MH, Grannemann BD, Garver CR, Johnson DG, Andrews AA, Savla JS, et al. 2007. Sensory correlations in autism. Autism 11:123-134.
188. Khandjian EW, Bardoni B, Corbin F, Sittler A, Giroux S, Heitz D, Tremblay S, et al. 1998. Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis. Hum Mol Genet 7:2121-2128.
189. Khandjian EW, Corbin F, Woerly S, Rousseau F. 1996. The fragile X mental retardation protein is associated with ribosomes. Nat Genet 12:91-93.
190. Khandjian EW, Fortin A, Thibodeau A, Tremblay S, Côté F, Devys D, Mandel JL, et al. 1995. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum Mol Genet 4:783-789.
191. Khandjian EW. 1999. Biology of the fragile X mental retardation protein, an RNA-binding protein. Biochem Cell Biol 77:331-342.
192. Khandjian EW, Huot M, Tremblay S, Davidovic L, Mazroui R, Bardoni B. 2004. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc Natl Acad Sci USA 101:13357-13362.
193. Kiebler MA, Bassell GJ. 2006. Neuronal RNA granules: Movers and makers. Neuron 51:685-690.
194. Kim M, Bellini M, Ceman S. 2009. Fragile X mental retardation protein FMRP binds mRNAs in the nucleus. Mol Cell Biol 29:214-228.
195. Kirkpatrick LL, McIlwain KA, Nelson DL. 2001. Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Genomics 78:169-177.
196. Klei L, Sanders SJ, Murtha MT, Hus V, Lowe JK, Willsey AJ, Moreno-De-Luca D, et al. 2012. Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism 3:9.
197. Klemmer P, Meredith RM, Holmgren CD, Klychnikov OI, Stahl-Zeng J, Loos M, Van der Schors RC, et al. 2011. Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype. J Biol Chem 286:25495-25504.
198. Knowles RB, Sabry JH, Martone ME, Deerinck TJ, Ellisman MH, Bassell GJ, Kosik KS. 1996. Translocation of RNA granules in living neurons. J Neurosci 16:7812-7820.
199. Kooy R Frank. 2003. Of mice and the fragile X syndrome. Trends Genet 19:148-154.
200. Kronk R, Bishop EE, Raspa M, Bickel JO, Mandel DA, Bailey DB. 2010. Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey. Sleep 33:679-687.
201. Krueger DD, Bear MF. 2011. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62:411-429.
202. Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF. 2011. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 108:2587-2592.
203. Krueger DD, Tuffy LP, Papadopoulos T, Brose N. 2012. The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr Opin Neurobiol 22:412-422.
204. Kwiatkowski DJ, Manning BD. 2005. Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 14:R251-R258.
205. Kwon C-H, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, et al. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377-388.
206. Köhrmann M, Luo M, Kaether C, Desgroseillers L, Dotti CG, Kiebler MA. 1999. Microtubule-dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol Biol Cell 10:2945-2953.
207. Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U. 2001. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10:329-338.
208. Lazarov O, Demars MP, Zhao KDT, Ali HM, Grauzas V, Kney A, Larson J. 2012. Impaired survival of neural progenitor cells in dentate gyrus of adult mice lacking FMRP. Hippocampus 22:1220-1224.
209. LeDoux J. 2003. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23:727-738.
210. Lee A, Li W, Xu K, Bogert BA, Su K, Gao F-B. 2003. Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Development 130:5543-5552.
211. Lee HYY, Ge W-P, Huang W, He Y, Wang GXX, Rowson-Baldwin A, Smith SJJ, et al. 2011. Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein. Neuron 72:630-642.
212. Lendvai B, Stern EA, Chen B, Svoboda K. 2000. Experience-dependent plasticity of dendritic spines in the developing rat barrel cortex in vivo. Nature 404:876-881.
213. Leung K-M, Van Horck FPG, Lin AC, Allison R, Standart N, Holt CE. 2006. Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1. Nat Neurosci 9:1247-1256.
214. Levy B, Steward O, Levy WB. 1982. Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus. J Neurosci 2:284-291.
215. Li C, Bassell GJ, Sasaki Y. 2009. Fragile X mental retardation protein is involved in protein synthesis-dependent collapse of growth cones induced by semaphorin-3A. Front Neural Circuits 3:11.
216. Li J, Pelletier MR, Perez Velazquez J-L, Carlen PL. 2002. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci 19:138-151.
217. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y. 2001. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res 29:2276-2283.
218. Loesch DZ, Huggins RM, Hagerman RJ. 2004. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev 10:31-41.
219. Luo Y, Shan G, Guo W, Smrt RD, Johnson EB, Li X, Pfeiffer RL, et al. 2010. Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet 6:e1000898.
220. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, et al. 1995. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14:433-445.
221. Manahan-Vaughan D, Kulla A, Frey JU. 2000. Requirement of translation but not transcription for the maintenance of long-term depression in the CA1 region of freely moving rats. J Neurosci 20:8572-8576.
222. Mao L, Yang L, Arora A, Choe ES, Zhang G, Liu Z, Fibuch EE, et al. 2005. Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons. J Biol Chem 280:12602-12610.
223. Mao L, Yang L, Tang Q, Samdani S, Zhang G, Wang JQ. 2005. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci 25:2741-2752.
224. Martin JP, Bell J. 1943. A pedigree of mental defect showing sex-linkage. J Neurol Psychiatry 6:154-157.
225. Martin KC, Casadio A, Zhu H, Yaping E, Rose JC, Chen M, Bailey CH, et al. 1997. Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: A function for local protein synthesis in memory storage. Cell 91:927-938.
226. Mazroui R, Huot M, Tremblay S, Filion C, Labelle Y, Khandjian EW. 2002. Trapping of messenger RNA by Fragile X mental retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet 11:3007-3017.
227. McBride SMJ, Choi CH, Wang Y, Liebelt D, Braunstein E, Ferreiro D, Sehgal A, et al. 2005. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45:753-764.
228. McKinney BC, Grossman AW, Elisseou NM, Greenough WT. 2005. Dendritic spine abnormalities in the occipital cortex of C57BL/6 Fmr1 knockout mice. Am J Med Genet B Neuropsychiatr Genet 136:98-102.
229. McNaughton CH, Moon J, Strawderman MS, Maclean KN, Evans J, Strupp BJ. 2008. Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav Neurosci 122:293-300.
230. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ. 2008. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28:5422-5432.
231. Menon RP, Gibson TJ, Pastore A. 2004. The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre. J Mol Biol 343:43-53.
232. Menon V, Leroux J, White CD, Reiss AL. 2004. Frontostriatal deficits in fragile X syndrome: Relation to FMR1 gene expression. Proc Natl Acad Sci USA 101:3615-3620.
233. Meredith RM, Holmgren CD, Weidum M, Burnashev N, Mansvelder HD. 2007. Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. Neuron 54:627-638.
234. Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, et al. 2012. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74:49-56.
235. Michaluk P, Wawrzyniak M, Alot P, Szczot M, Wyrembek P, Mercik K, Medvedev N, et al. 2011. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. J Cell Sci 124:3369-3380.
236. Mientjes EJ, Willemsen R, Kirkpatrick LL, Nieuwenhuizen IM, Hoogeveen-Westerveld M, Verweij M, Reis S, et al. 2004. Fxr1 knockout mice show a striated muscle phenotype: Implications for Fxr1p function in vivo. Hum Mol Genet 13:1291-1302.
237. Miles JH. 2011. Autism spectrum disorders-A genetics review. Genet Med 13:278-294.
238. Mili S, Moissoglu K, Macara IG. 2008. Genome-wide screen reveals APC-associated RNAs enriched in cell protrusions. Nature 453:115-119.
239. Miller LC, Blandford V, McAdam R, Sanchez-Carbente MR, Badeaux F, DesGroseillers L, Sossin WS. 2009. Combinations of DEAD box proteins distinguish distinct types of RNA: Protein complexes in neurons. Mol Cell Neurosci 40:485-495.
240. Min WW, Yuskaitis CJ, Yan Q, Sikorski C, Chen S, Jope RS, Bauchwitz RP. 2009. Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential. Neuropharmacology 56:463-472.
241. Mines MA, Yuskaitis CJ, King MK, Beurel E, Jope RS. 2010. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. PLoS One 5:e9706.
242. Ming G, Song H. 2005. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223-250.
243. Miyashiro K, Dichter M, Eberwine J. 1994. On the nature and differential distribution of mRNAs in hippocampal neurites: Implications for neuronal functioning. Proc Natl Acad Sci USA 91:10800-10804.
244. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, Liu L, Carbonetto S, et al. 2003. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37:417-431.
245. Morgan IG, Austin L. 1968. Synaptosomal protein synthesis in a cell-free system. J Neurochem 15:41-51.
246. Muddashetty RS, Kelić S, Gross C, Xu M, Bassell GJ. 2007. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 27:5338-5348.
247. Muddashetty RS, Nalavadi VC, Gross C, Yao X, Xing L, Laur O, Warren ST, et al. 2011. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR Signaling. Mol Cell 42:673-688.
248. Mínguez M, Ibáñez B, Ribate M-P, Ramos F, García-Alegría E, Fernández-Rivas A, Ruiz-Parra E, et al. 2009. Risk of cognitive impairment in female premutation carriers of fragile X premutation: Analysis by means of robust segmented linear regression models. Am J Med Genet B Neuropsychiatr Genet 150:262-270.
249. Nalavadi VC, Muddashetty RS, Gross C, Bassell GJ. 2012. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: A role in immediate early mGluR-stimulated translation. J Neurosci 32:2582-2587.
250. Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S, Di Marino D, et al. 2008. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134:1042-1054.
251. Narayanan U, Nalavadi V, Nakamoto M, Pallas DC, Ceman S, Bassell GJ, Warren ST. 2007. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 27:14349-14357.
252. Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, Bassell GJ, Warren ST. 2008. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem 283:18478-18482.
253. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin C-F, et al. 2012. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485:242-245.
254. Neves-Pereira M, Müller B, Massie D, Williams JHG, O'Brien PCM, Hughes A, Shen S-B, et al. 2009. Deregulation of EIF4E: A novel mechanism for autism. J Med Genet 46:759-765.
255. Niere F, Wilkerson JR, Huber KM. 2012. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. J Neurosci 32:5924-5936.
256. Nilsen TW. 2007. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends in genetics 23:243-249.
257. Nimchinsky EA, Oberlander AM, Svoboda K. 2001. Abnormal development of dendritic spines in FMR1 knockout mice. J Neurosci 21:5139-5146.
258. Nosyreva ED, Huber KM. 2006. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J Neurophysiol 95:3291-3295.
259. Olmos-Serrano JL, Paluszkiewicz SM, Martin BS, Kaufmann WE, Corbin JG, Huntsman MM. 2010. Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 30:9929-9938.
260. Olsen PH, Ambros V. 1999. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216:671-680.
261. Osterweil EK, Kind PC, Bear MF. 2012. Lifting the mood on treating fragile x. Biol Psychiatry 72:895-897.
262. Osterweil EK, Krueger DD, Reinhold K, Bear MF. 2010. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci 30:15616-15627.
263. O'Neill M, Jones RS. 1997. Sensory-perceptual abnormalities in autism: A case for more research? J Autism Dev Disord 27:283-293.
264. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, et al. 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43:585-589.
265. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, et al. 2012. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:246-250.
266. Pacey LKK, Doering LC. 2007. Developmental expression of FMRP in the astrocyte lineage: Implications for fragile X syndrome. Glia 55:1601-1609.
267. Paluszkiewicz SM, Martin BS, Huntsman MM. 2011. Fragile X syndrome: The GABAergic system and circuit dysfunction. Dev Neurosci 33:349-364.
268. Pan L, Woodruff E, Liang P, Broadie K. 2008. Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling. Mol Cell Neurosci 37:747-760.
269. Pan L, Zhang Yong Q, Woodruff E, Broadie K. 2004. The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation. Curr Biol 14:1863-1870.
270. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST. 1999. Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94:185-192.
271. Park S, Park JM, Kim S, Kim J-A, Shepherd JD, Smith-Hicks CL, Chowdhury S, et al. 2008. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59:70-83.
272. Parmentier ML, Pin JP, Bockaert J, Grau Y. 1996. Cloning and functional expression of a Drosophila metabotropic glutamate receptor expressed in the embryonic CNS. J Neurosci 16:6687-6694.
273. Paul K, Venkitaramani DV, Cox CL. 2013. Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice. J Physiol 591:1133-1143.
274. Petit TL, LeBoutillier JC, Gregorio A, Libstug H. 1988. The pattern of dendritic development in the cerebral cortex of the rat. Brain Res 469:209-219.
275. Peça J, Feng G. 2012. Cellular and synaptic network defects in autism. Curr Opin Neurobiol 22:1-7.
276. Pfeiffer BE, Huber KM. 2007. Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. J Neurosci 27:3120-3130.
277. Pfeiffer BE, Huber KM. 2009. The state of synapses in fragile X syndrome. Neuroscientist 15:549-67.
278. Pfeiffer BE, Zang T, Wilkerson JR, Taniguchi M, Maksimova MA, Smith LN, Cowan CW, et al. 2010. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 66:191-197.
279. Piazzon N, Rage F, Schlotter F, Moine H, Branlant C, Massenet S. 2008. In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein. J Biol Chem 283:5598-5610.
280. Pilpel Y, Kolleker A, Berberich S, Ginger M, Frick A, Mientjes E, Oostra BA, et al. 2009. Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice. J Physiol 587:787-804.
281. Plante I, Davidovic L, Ouellet DL, Gobeil L-A, Tremblay S, Khandjian EW, Provost P. 2006. Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs. J Biomed Biotechnol 2006:64347.
282. Portera-Cailliau C. 2012. Which comes first in fragile X syndrome, dendritic spine dysgenesis or defects in circuit plasticity? Neuroscientist 18:28-44.
283. Price DK, Zhang F, Ashley CT, Warren ST. 1996. The chicken FMR1 gene is highly conserved with a CCT 5'-untranslated repeat and encodes an RNA-binding protein. Genomics 31:3-12.
284. Price TJ, Flores CM, Cervero F, Hargreaves KM. 2006. The RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axons. Neuroscience 141:2107-2116.
285. Qin M, Kang J, Burlin T V, Jiang C, Smith CB. 2005. Postadolescent changes in regional cerebral protein synthesis: An in vivo study in the FMR1 null mouse. J Neurosci 25:5087-5095.
286. Reeve SP, Bassetto L, Genova GK, Kleyner Y, Leyssen M, Jackson FR, Hassan BA. 2005. The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Curr Biol 15:1156-1163.
287. Reiss AL, Freund LS, Baumgardner TL, Abrams MT, Denckla MB. 1995. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11:331-334.
288. Restivo L, Ferrari F, Passino E, Sgobio C, Bock J, Oostra BA, Bagni C, et al. 2005. Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc Natl Acad Sci USA 102:11557-11562.
289. Roberts JE, Mankowski JB, Sideris J, Goldman BD, Hatton DD, Mirrett PL, Baranek GT, et al. 2009. Trajectories and predictors of the development of very young boys with fragile X syndrome. J Pediatr Psychol 34:827-836.
290. Rogers SJ, Wehner DE, Hagerman R. 2001. The behavioral phenotype in fragile X: Symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr 22:409-417.
291. Ronesi JA, Huber KM. 2008. Metabotropic glutamate receptors and fragile x mental retardation protein: Partners in translational regulation at the synapse. Sci Signal 1:pe6.
292. De Rubeis S, Bagni C. 2010. Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability. Mol Cell Neurosci 43:43-50.
293. De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C. 2012. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: From gene mutation/s to spine dysmorphogenesis. Adv Exp Med Biol 970:517-551.
294. Saffary R, Xie Z. 2011. FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development. J Neurosci 31:1427-1439.
295. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE, Zoghbi HY. 2011. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 3:86ra49.
296. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, et al. 2012. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237-241.
297. Santini E, Huynh TN, MacAskill AF, Carter AG, Pierre P, Ruggero D, Kaphzan H, Klann E. 2013. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature 493:411-415.
298. Scheetz A, Nairn A. 2000. NMDA receptor-mediated control of protein synthesis at developing synapses. Nat Neurosci 3:211-216.
299. Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL. 2001. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci USA 98:8844-8849.
300. Schenck A, Bardoni B, Langmann C, Harden N, Mandel J, Giangrande A. 2003. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 38:887-898.
301. Schumann CM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, Buonocore MH, Lammers CR, et al. 2004. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24:6392-6401.
302. Scotto-Lomassese S, Nissant A, Mota T, Néant-Féry M, Oostra BA, Greer CA, Lledo P-M, et al. 2011. Fragile X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb. J Neurosci 31:2205-2215.
303. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, et al. 2007. Strong association of de novo copy number mutations with autism. Science 316:445-449.
304. Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, Zukin RS. 2010. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30:694-702.
305. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, et al. 2011. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 6:e26203.
306. Shiina N, Shinkura K, Tokunaga M. 2005. A novel RNA-binding protein in neuronal RNA granules: Regulatory machinery for local translation. J Neurosci 25:4420-4434.
307. Siller SS, Broadie K. 2011. Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase. Dis Model Mech 4:673-685.
308. Singer RH. 1992. The cytoskeleton and mRNA localization. Curr Opin Cell Biol 4:15-19.
309. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G. 1994. Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39.
310. Siomi MC, Zhang Y, Siomi H, Dreyfuss G. 1996. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 16:3825-3832.
311. Smith LE, Barker ET, Seltzer MM, Abbeduto L, Greenberg JS. 2012. Behavioral phenotype of fragile X syndrome in adolescence and adulthood. Am J Intellect Dev Disabil 117:1-17.
312. Snyder EM, Philpot BD, Huber KM, Dong X, Fallon JR, Bear MF. 2001. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat Neurosci 4:1079-1085.
313. Sossin WS, DesGroseillers L. 2006. Intracellular trafficking of RNA in neurons. Traffic 7:1581-1589.
314. State MW, Sestan N. 2012. Neuroscience. The emerging biology of autism spectrum disorders. Science 337:1301-1303.
315. Stefani G, Fraser CE, Darnell JC, Darnell RB. 2004. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci 24:7272-7276.
316. Stetler A, Winograd C, Sayegh J, Cheever A, Patton E, Zhang X, Clarke S, et al. 2006. Identification and characterization of the methyl arginines in the fragile X mental retardation protein Fmrp. Hum Mol Genet 15:87-96.
317. Steward O, Bakker CE, Willems PJ, Oostra BA. 1998. No evidence for disruption of normal patterns of mRNA localization in dendrites or dendritic transport of recently synthesized mRNA in FMR1 knockout mice, a model for human fragile-X mental retardation syndrome. Neuroreport 9:477-481.
318. Steward O, Falk PM. 1985. Polyribosomes under developing spine synapses: Growth specializations of dendrites at sites of synaptogenesis. J Neurosci Res 13:75-88.
319. Steward O, Reeves TM. 1988. Protein-synthetic machinery beneath postsynaptic sites on CNS neurons: Association between polyribosomes and other organelles at the synaptic site. J Neurosci 8:176-184.
320. Steward O, Ribak CE. 1986. Polyribosomes associated with synaptic specializations on axon initial segments: Localization of protein-synthetic machinery at inhibitory synapses. J Neurosci 6:3079-3085.
321. Steward O, Wallace CS, Lyford GL, Worley PF. 1998. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 21:741-751.
322. Steward O. 1983. Alterations in polyribosomes associated with dendritic spines during the reinnervation of the dentate gyrus of the adult rat. J Neurosci 3:177.
323. Strumbos JG, Brown MR, Kronengold J, Polley DB, Kaczmarek LK. 2010. Fragile X mental retardation protein is required for rapid experience-dependent regulation of the potassium channel Kv3.1b. J Neurosci 30:10263-10271.
324. Suvrathan A, Chattarji S. 2011. Fragile X syndrome and the amygdala. Curr Opin Neurobiol 21:509-515.
325. Suvrathan A, Hoeffer Charles A, Wong Helen, Klann Eric, Chattarji S. 2010. Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 107:11591-11596.
326. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Südhof TC. 2007. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318:71-76.
327. Tamanini F, Meijer N, Verheij C, Willems PJ, Galjaard H, Oostra BA, Hoogeveen AT. 1996. FMRP is associated to the ribosomes via RNA. Hum Mol Genet 5:809-813.
328. Tamanini F, Willemsen R, Van Unen L, Bontekoe C, Galjaard H, Oostra BA, Hoogeveen AT. 1997. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet 6:1315-1322.
329. Tang SJ, Reis G, Kang Hyejin, Gingras A-C, Sonenberg N, Schuman EM. 2002. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 99:467-472.
330. Tassone F, Hagerman RJ, Iklé DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, et al. 1999. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84:250-261.
331. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. 2000. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15.
332. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman P J. 2000. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 91:144-152.
333. Tassone F, Hagerman R. 2012. The fragile X-associated tremor ataxia syndrome. Results Probl Cell Differ 54:337-357.
334. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. 2002. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99:13571-13576.
335. Telias M, Segal M, Ben-Yosef D. 2013. Neural differentiation of fragile X human embryonic stem cells reveals abnormal patterns of development despite successful neurogenesis. Dev Biol 374:32-45.
336. Tervonen TA, Louhivuori V, Sun X, Hokkanen M-E, Kratochwil CF, Zebryk P, Castrén E, et al. 2009. Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis 33:250-259.
337. Tessier CR, Broadie K. 2008. Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning. Development 135:1547-1557.
338. Thomas CC, Combe CL, Dyar KA, Inglis FM. 2008. Modest alterations in patterns of motor neuron dendrite morphology in the Fmr1 knockout mouse model for fragile X. Int J Dev Neurosci 26:805-811.
339. Till SM, Wijetunge LS, Seidel VG, Harlow E, Wright AK, Bagni C, Contractor A, et al. 2012. Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Hum Mol Genet 21:2143-2156.
340. Todd PK, Mack KJ. 2000. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. Brain Res Mol Brain Res 80:17-25.
341. Todd PK, Mack KJ, Malter JS. 2003. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci USA 100:14374-14378.
342. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, et al. 2010. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in genetics 26:363-372.
343. Trinh MA, Kaphzan H, Wek RC, Pierre P, Cavener DR, Klann Eric. 2012. Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep 1:676-688.
344. Tucker B, Richards R, Lardelli M. 2004. Expression of three zebrafish orthologs of human FMR1-related genes and their phylogenetic relationships. Dev Genes Evol 214:567-574.
345. Vanderklish PW, Edelman GM. 2002. Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons. Proc Natl Acad Sci USA 99:1639-1644.
346. Van't Padje S, Engels B, Blonden L, Severijnen L-A, Verheijen F, Oostra B, Willemsen R. 2005. Characterisation of Fmrp in zebrafish: Evolutionary dynamics of the fmr1 gene. Dev Genes Evol 215:198-206.
347. Vasudevan S, Steitz J. 2007. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128:1105-1118.
348. Verheij C, Bakker CE, De Graaff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, et al. 1993. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
349. Verkerk AJ, De Graaff E, De Boulle K, Eichler EE, Konecki DS, Reyniers E, Manca A, et al. 1993. Alternative splicing in the fragile X gene FMR1. Hum Mol Genet 2:1348.
350. Verkerk AJ, Pieretti M, Sutcliffe J, Fu Y, Kuhl DP, Pizzuti A, Reiner O, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
351. Wan L, Dockendorff TC, Jongens TA, Dreyfuss G. 2000. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol Cell Biol 20:8536-8547.
352. Wang H, Dictenberg JB, Ku L, Li W, Bassell GJ, Feng Y. 2008. Dynamic association of the fragile X mental retardation protein as a messenger ribonucleoprotein between microtubules and polyribosomes. Mol Biol Cell 19:105-114.
353. Wang H, Wu L-J, Kim SS, Lee FJS, Gong B, Toyoda H, Ren M, et al. 2008. FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59:634-647.
354. Wang H, Iacoangeli A, Lin D, Williams K, Denman RB, Hellen C, Tiedge H. 2005. Dendritic BC1 RNA in translational control mechanisms. J Cell Biol 171:811-821.
355. Waung MW, Pfeiffer BE, Nosyreva ED, Ronesi J, Huber Kimberly M. 2008. Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Neuron 59:84-97.
356. Weiler IJ, Greenough WT. 1993. Metabotropic glutamate receptors trigger postsynaptic protein synthesis. Proc Natl Acad Sci USA 90:7168-7171.
357. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, et al. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.
358. Weiler IJ, Spangler CC, Klintsova AY, Grossman AW, Kim SH, Bertaina-Anglade V, Khaliq H, et al. 2004. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc Natl Acad Sci USA 101:17504-17509.
359. Westmark CJ, Malter JS. 2007. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 5:e52.
360. Westmark CJ, Westmark PR, O'Riordan KJ, Ray BC, Hervey CM, Salamat MS, Abozeid SH, et al. 2011. Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice. PLoS One 6:e26549.
361. Whitman S, Cover C, Yu L, Nelson DL, Zarnescu DC, Gregorio CC. 2011. Desmoplakin and Talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle whitman; Dsp and Tln2 are mRNA targets of FXR1 in the heart. Circ Res 85724:1-10.
362. Willemsen Rob, Bontekoe CJM, Severijnen L-A, Oostra Ben A. 2002. Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum Genet 110:601-605.
363. Wilson BM, Cox CL. 2007. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc Natl Acad Sci USA 104:2454-2459.
364. Winarni TI, Schneider A, Borodyanskara M, Hagerman Randi J. 2012. Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome. Case Rep Genet 2012:280813.
365. Wu KY, Hengst U, Cox LJ, Macosko EZ, Jeromin A, Urquhart ER, Jaffrey SR. 2005. Local translation of RhoA regulates growth cone collapse. Nature 436:1020-1024.
366. Xinyuanhe C, Portera-Cailliau C. 2012. The trouble with spines in fragile X syndrome: Density, maturity and plasticity. Neuroscience http://dx.doi.org/10.1016/j.neuroscience.2012.03.049.
367. Xu X-L, Li Yan, Wang F, Gao F-B. 2008. The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila. J Neurosci 28:11883-11889.
368. Yan QJ, Rammal M, Tranfaglia M, Bauchwitz RP. 2005. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49:1053-1066.
369. Yang Y, Xu S, Xia L, Wang J, Wen S, Jin P, Chen D. 2009. The bantam microRNA is associated with drosophila fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genet 5:e1000444.
370. Yin HH, Davis MI, Ronesi JA, Lovinger DM. 2006. The role of protein synthesis in striatal long-term depression. J Neurosci 26:11811-11820.
371. Yun SH, Trommer BL. 2011. Fragile X mice: Reduced long-term potentiation and N-methyl-D-aspartate receptor-mediated neurotransmission in dentate gyrus. J Neurosci Res 89:176-182.
372. Yuskaitis CJ, Mines MA, King MK, Sweatt JD, Miller CA, Jope RS. 2010. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochem Pharmacol 79:632-646.
373. Zalfa F, Adinolfi S, Napoli I, Kühn-Hölsken E, Urlaub H, Achsel T, Pastore A, et al. 2005. Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J Biol Chem 280:33403-33410.
374. Zalfa F, Bagni C. 2004. Molecular insights into mental retardation: Multiple functions for the Fragile X mental retardation protein? Curr Issues Mol Biol 6:73-88.
375. Zalfa F, Eleuteri B, Dickson KS, Mercaldo V, De Rubeis S, Di Penta A, Tabolacci E, et al. 2007. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10:578-587.
376. Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S, Oostra B, et al. 2003. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112:317-327.
377. Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, Zhong R, Stone EF, et al. 2009. A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet 5:e1000758.
378. Zangenehpour S, Cornish KM, Chaudhuri A. 2009. Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome. Brain Res 1264:76-84.
379. Zhang J, Hou L, Klann Eric, Nelson David L. 2009. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. J Neurophysiol 101:2572-2580.
380. Zhang Y, O'Connor JP, Siomi M C, Srinivasan S, Dutra A, Nussbaum RL, Dreyfuss G. 1995. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J 14:5358-5366.
381. Zhang YQ, Bailey AM, Matthies HJ, Renden RB, Smith MA, Speese SD, Rubin GM, et al. 2001. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107:591-603.
382. Zhang Y, Venkitaramani DV, Gladding CM, Zhang Y, Kurup P, Molnar E, Collingridge GL, Lombroso PJ. 2008. The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J Neurosci 28:10561-10566.
383. Zhao M-G, Toyoda H, Ko SW, Ding H-K, Wu L-J, Zhuo M. 2005. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci 25:7385-7392.
384. Zhong J, Zhang T, Bloch LM. 2006. Dendritic mRNAs encode diversified functionalities in hippocampal pyramidal neurons. BMC Neurosci 7:17.
385. Zhu PJ, Huang W, Kalikulov D, Yoo JW, Placzek AN, Stoica L, Zhou H, et al. 2011. Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell 147:1384-1396.
386. Zoghbi HY, Bear Mark F. 2012. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 4:a009886.